<SEC-DOCUMENT>0001640334-17-002570-index.html : 20180830
<SEC-HEADER>0001640334-17-002570.hdr.sgml : 20180830
<ACCEPTANCE-DATETIME>20171130214105
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001640334-17-002570
CONFORMED SUBMISSION TYPE:	DRS
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20171201
<PUBLIC-REL-DATE>20180830
DATE AS OF CHANGE:		20180102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Inmune Bio, Inc.
		CENTRAL INDEX KEY:			0001711754
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				475205835
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DRS
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	377-01812
		FILM NUMBER:		171232585

	BUSINESS ADDRESS:	
		STREET 1:		1224 PROSPECT STREET
		STREET 2:		SUITE 150
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		8589643720

	MAIL ADDRESS:	
		STREET 1:		1224 PROSPECT STREET
		STREET 2:		SUITE 150
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRS
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
Document 1 - file: filename1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>filename2.htm
<TEXT>
Document 2 - file: filename2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>filename3.htm
<TEXT>
Document 3 - file: filename3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>filename4.htm
<TEXT>
Document 4 - file: filename4.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>5
<FILENAME>filename5.htm
<TEXT>
Document 5 - file: filename5.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>6
<FILENAME>filename6.htm
<TEXT>
Document 6 - file: filename6.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>7
<FILENAME>filename7.htm
<TEXT>
Document 7 - file: filename7.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>inmune_ex31img19.jpg
<TEXT>
Document 8 - file: inmune_ex31img19.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>inmune_ex31img20.jpg
<TEXT>
Document 9 - file: inmune_ex31img20.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>inmune_ex31img21.jpg
<TEXT>
Document 10 - file: inmune_ex31img21.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>inmune_ex31img22.jpg
<TEXT>
Document 11 - file: inmune_ex31img22.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>inmune_ex31img23.jpg
<TEXT>
Document 12 - file: inmune_ex31img23.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>inmune_ex31img24.jpg
<TEXT>
Document 13 - file: inmune_ex31img24.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>inmune_ex31img25.jpg
<TEXT>
Document 14 - file: inmune_ex31img25.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>inmune_ex31img26.jpg
<TEXT>
Document 15 - file: inmune_ex31img26.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>inmune_ex31img27.jpg
<TEXT>
Document 16 - file: inmune_ex31img27.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>inmune_ex106img1.jpg
<TEXT>
Document 17 - file: inmune_ex106img1.jpg

</DOCUMENT>
</SEC-DOCUMENT>